Back
Evovest Global Equity ETF Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Buy
63
EVO.TO
Evovest Global Equity ETF
Last Price:
$27.91
Seasonality Move:
4.05%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Buy
63
Evovest Global Equity ETF (EVO.TO)
is a Buy
Is Evovest Global Equity ETF a Buy, Sell or Hold?
-
The current Evovest Global Equity ETF [EVO.TO] share price is $27.91. The Score for EVO.TO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
EVO.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.59. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVO.TO Stock Price Chart
What is Evovest Global Equity ETF's stock price today?
-
The Evovest Global Equity ETF share price today is $27.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVO.TO is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.59The current trend is moderately bearish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
EVO.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 58.2 | Buy |
| Chaikin Money Flow: | 8401 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.16 - 27.94) | Buy |
| Bollinger Bands (100): | (26.72 - 27.64) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -1420728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.45 - 47.99) | Sell |
| Bollinger Bands (100): | (29.17 - 43.09) | Buy |
EVO.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Buy |
| 20-day SMA: | 27.73 | Buy |
| 50-day SMA: | 27.43 | Buy |
| 200-day SMA: | 25.85 | Buy |
| 8-day EMA: | 27.78 | Buy |
| 20-day EMA: | 27.67 | Buy |
| 50-day EMA: | 27.45 | Buy |
| 200-day EMA: | 25.95 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Sell |
| 20-day SMA: | 45.09 | Sell |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 27.66 | Buy |
| 8-day EMA: | 42.28 | Sell |
| 20-day EMA: | 42.74 | Sell |
| 50-day EMA: | 39.8 | Buy |
| 200-day EMA: | 30.28 | Buy |
Evovest Global Equity ETF Earnings Growth & EVO.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Evovest Global Equity ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||